Pharmaceuticals

Global Angina Pectoris Drugs Market 2025–2029: Competitive Insights and Opportunities

November 11, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Market Value Is The Angina Pectoris Drugs Industry Expected To Reach By 2029, Starting From 2025 Levels?

The angina pectoris drugs market has experienced consistent expansion in its size over recent years. It is projected to increase from $12.32 billion in 2024 to $12.88 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 4.5%. The market’s past growth can be linked to the high prevalence of cardiovascular diseases, aging population demographics, various lifestyle factors, an increase in hypertension rates, and the widespread occurrence of diabetes.

The angina pectoris drugs market is anticipated to experience substantial expansion over the coming years. This market is projected to reach $16.42 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 6.3%. Key factors contributing to this projected growth include increasing global obesity levels, innovations in precision medicine, a greater emphasis on preventive cardiology, efforts in patient education, and ongoing investigations into new therapeutic approaches. Significant trends expected during this period encompass the use of telemedicine for distant patient monitoring, the development of real-world evidence and outcome research, patient-focused medication education, the formation of strategic partnerships to enhance market access, progress in regulatory frameworks, and accelerated approval processes.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10797&type=smp

Which Major Market Drivers Are Shaping The Future Of The Angina Pectoris Drugs Market?

The rising occurrence of cardiovascular diseases is anticipated to fuel the expansion of the angina pectoris drug market moving ahead. These diseases encompass various ailments affecting the heart and blood vessels, such as coronary artery disease, high blood pressure, heart failure, and stroke. The growing incidence of cardiovascular diseases (CVD) is linked to factors like an older population, poor lifestyle choices, and the widespread issue of obesity. Drugs for angina pectoris, including nitrates, beta-blockers, and calcium channel blockers, efficiently alleviate chest pain and discomfort resulting from inadequate blood supply to the heart, consequently improving patients’ general well-being. As an illustration, data released by the British Heart Foundation, a UK-based cardiovascular research charity, indicated that in September 2024, approximately 7.6 million individuals in the UK suffer from heart and circulatory diseases, comprising roughly 4 million males and 3.6 million females. These illnesses account for about 27% of all fatalities in the UK, which translates to over 170,000 deaths annually, or roughly 480 deaths each day, meaning one death occurs every three minutes. Consequently, the increasing prevalence of cardiovascular diseases is boosting the expansion of the angina pectoris drug market.

What Are The Major Segments Identified In The Angina Pectoris Drugs Market?

The angina pectoris drugs market covered in this report is segmented –

1) By Drugs: Nitrates, Antiplatelet Agents, Beta-adrenergic Blocking Agents, Calcium Channel Blockers, Anti-ischemic Agents, Statins, Antihypertensive Agents, Other Drugs

2) By Indication: Stable Angina, Unstable Angina, Prinzmetal’s Angina

3) By Route of Administration: Oral, Parenteral, Transdermal, Other Route Of Administrations

4) By End User: Hospitals, Homecare, Specialty Clinics, Other End Users

Subsegments:

1) By Nitrates: Short-Acting Nitrates, Long-Acting Nitrates

2) By Antiplatelet Agents: Aspirin, Clopidogrel

3) By Beta-Adrenergic Blocking Agents: Non-Selective Beta Blockers, Selective Beta Blockers

4) By Calcium Channel Blockers: Dihydropyridine Calcium Channel Blockers, Non-dihydropyridine Calcium Channel Blockers

5) By Anti-Ischemic Agents: Ranolazine, Ivabradine

6) By Statins: Atorvastatin, Rosuvastatin

Which Market Trends Are Creating New Opportunities In The Angina Pectoris Drugs Industry?

A prominent and expanding trend in the angina pectoris drugs market is product innovation. Key companies in the angina pectoris drug market are employing new technologies to uphold their market presence. For example, Hikma Pharmaceuticals PLC, a UK-based pharmaceutical enterprise, introduced Labetalol Hydrochloride Injection, USP, in a prefilled syringe in March 2023. This product has been approved by the United States Food and Drug Administration. The 10 mg/2 mL PFS is utilized in hospitals for managing severe hypertension and decreasing blood pressure.

Which Leading Companies Dominate The Angina Pectoris Drugs Market Share?

Major companies operating in the angina pectoris drugs market include Astellas Pharma Inc., Bayer AG, Novartis AG, AstraZeneca PLC, Bausch Health Companies Inc., Merck & Co Inc., Eli Lilly and Company, Pfizer Inc., Abbott Laboratories, Sun Pharmaceutical Industries Limited, Sanofi SA, Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, Johnson & Johnson, AERIE PHARMACEUTICALS INC., AbbVie Inc., Amgen Inc., Gilead Sciences Inc., GlaxoSmithKline plc, H. Lundbeck A/S, Ipsen S.A., Lupin Pharmaceuticals Inc., Merck KGaA, Otsuka Pharmaceutical Co. Ltd., Regeneron Pharmaceuticals Inc., Servier Laboratories, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., UCB S.A.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/angina-pectoris-drugs-global-market-report

How Is Angina Pectoris Drugs Market Demand Varying Across Different Regions?

North America was the largest region in the angina pectoris drugs market in 2024.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the angina pectoris drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request A Customized Version Of The Angina Pectoris Drugs Market Report:

https://www.thebusinessresearchcompany.com/customise?id=10797&type=smp

Browse Through More Reports Similar to the Global Angina Pectoris Drugs Market 2025, By The Business Research Company

Muscle Relaxant Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/muscle-relaxant-drugs-global-market-report

Alzheimers Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/alzheimers-drugs-global-market-report

Osteoporosis Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/osteoporosis-drugs-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795